Oxylanosterols as modifiers of cholesterol biosynthesis
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Progress in Lipid Research
- Vol. 34 (2) , 99-116
- https://doi.org/10.1016/0163-7827(94)00008-a
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- The LDL Receptor Gene: A Mosaic of Exons Shared with Different ProteinsScience, 1985
- Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterolJournal of Lipid Research, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Post-HMG CoA reductase regulation of cholesterol biosynthesis in normal human lymphocytes: Lanosten-3β-ol-32-al, a natural inhibitorBiochemical and Biophysical Research Communications, 1981
- Studies on the mechanism of lanosterol 14 α-demethylation. A requirement for two distinct types of mixed-function-oxidase systemsBiochemical Journal, 1979
- Cholesterol in the Prediction of Atherosclerotic DiseaseAnnals of Internal Medicine, 1979
- Biological Activity of Some Oxygenated SterolsScience, 1978
- The pathway for the removal of the 15α-methyl group of lanosterolBioorganic Chemistry, 1977
- Lanosterol 14α-demethylase. The metabolism of some potential intermediates by cell-free systems from rat liverBiochemical and Biophysical Research Communications, 1976